Resultados de la búsqueda

Moreno PR, Astudillo L, Elmariah S, Purushothaman KR, Purushothaman M, Lento PA, Sharma SK, Fuster V, Adams DH. Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis. J Thorac Cardiov Sur (2011) 42:895-901

Fernandez-Friera L, Garcia-Alvarez A, Bagheriannejad-Esfahani F, Malick W, Mirelis JG, Sawit ST, Fuster V, Sanz J, Garcia MJ, Hermann LK. Diagnostic value of coronary artery calcium scoring in low-intermediate risk patients evaluated in the emergency department for acute coronary syndrome. Am J Cardiol (2011) 107:17-23

Falk E, Sillesen H, Muntendam P, Fuster V. The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population. Curr Atheroscler Rep (2011) 13:359-66

Fuster V, Sanz G. [Fixed-dose compounds and the secondary prevention of ischemic heart disease] Rev Esp Cardiol (2011) 64:3-9

Franco M, Cooper R, Bilal U, Fuster V. Control of Coronary Heart Disease Risk Factors and Evidence-Based Therapies: Joint Efforts for Coronary Heart Disease Prevention in Spain. Rev Esp Cardiol (2011) 64:962-4

Sanz G, Fuster V. Polypill and global cardiovascular health strategies. Semin Thorac Cardiovasc Surg. (2011) 21:24-9

Sanz J, Fuster V. Update in Cardiology. Ann Intern Med (2010) 152:786-91

Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol (2010) 55:1487-98

Zaitsev S, Spitzer D, Murciano JC, Ding BS, Tliba S, Kowalska MA, Marcos-Contreras OA, Kuo A, Stepanova V, Atkinson JP, Poncz M, Cines DB, Muzykantov VR. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation. Blood (2010) 115:5241-8

Moreno PR, Sanz J, Fuster V. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol (2009) 53:2315-23